Institutional Ownership Collegium Pharmaceutical, Inc (COLL)
This table provides information about the institutional ownership of Collegium Pharmaceutical, Inc (COLL). We have compiled data on the 247 institutions that hold shares in the stock, with a total of 37.4 Million shares, which have been reported (via 13F filing form) to have a value of $1.08 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,793,383
shares
|
$172 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.24%
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,638,702
shares
|
$78.3 Million
1.45% of portfolio
|
Q4 2024
Added 0.13%
|
|
Rubric Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,350,000
shares
|
$69.7 Million
1.11% of portfolio
|
Q4 2024
Added 88.0%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,282,666
shares
|
$67.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.72%
|
|
Pacer Advisors, Inc.
Malvern, PA |
Jan 22, 2025 Q4 2024 |
2,142,491
shares
|
$63.5 Million
0.15% of portfolio
|
Q4 2024
Reduced 17.27%
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
1,775,760
shares
|
$52.7 Million
0.01% of portfolio
|
Q4 2024
Added 19.47%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,661,549
shares
|
$49.3 Million
0.08% of portfolio
|
Q4 2024
Added 0.33%
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
1,645,051
shares
|
$48.8 Million
0.03% of portfolio
|
Q4 2024
New holding
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,437,154
shares
|
$42.6 Million
0.0% of portfolio
|
Q4 2024
Added 4.65%
|
|
Fuller & Thaler Asset Management, Inc.
San Mateo, CA |
Feb 14, 2025 Q4 2024 |
1,351,880
shares
|
$40.1 Million
0.15% of portfolio
|
Q4 2024
Reduced 1.32%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
975,814
shares
|
$28.9 Million
0.01% of portfolio
|
Q4 2024
Reduced 6.95%
|
|
Emerald Advisers, LLC
|
Feb 11, 2025 Q4 2024 |
811,680
shares
|
$24.1 Million
0.99% of portfolio
|
Q4 2024
Reduced 1.89%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
770,481
shares
|
$22.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.66%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
679,339
shares
|
$20.1 Million
0.0% of portfolio
|
Q4 2024
Added 11.05%
|
|
Massachusetts Financial Services CO
Boston, MA |
Feb 12, 2025 Q4 2024 |
604,199
shares
|
$17.9 Million
0.01% of portfolio
|
Q4 2024
Reduced 21.09%
|
|
Emerald Mutual Fund Advisers Trust
|
Feb 14, 2025 Q4 2024 |
569,567
shares
|
$16.9 Million
1.12% of portfolio
|
Q4 2024
Reduced 14.0%
|
|
Victory Capital Management Inc
|
Feb 06, 2025 Q4 2024 |
559,536
shares
|
$16.6 Million
0.02% of portfolio
|
Q4 2024
Reduced 21.27%
|
|
Lsv Asset Management
Chicago, IL |
Feb 13, 2025 Q4 2024 |
390,451
shares
|
$11.6 Million
0.03% of portfolio
|
Q4 2024
Reduced 13.47%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
385,157
shares
|
$11.4 Million
0.0% of portfolio
|
Q4 2024
Added 5.62%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
367,406
shares
|
$10.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.69%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
352,971
shares
|
$10.5 Million
0.0% of portfolio
|
Q4 2024
Added 168.74%
|
|
Royce & Associates LP
|
Feb 10, 2025 Q4 2024 |
339,529
shares
|
$10.1 Million
0.09% of portfolio
|
Q4 2024
Added 11.01%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
291,388
shares
|
$8.64 Million
0.0% of portfolio
|
Q4 2024
Added 319.35%
|
|
Quantedge Capital Pte LTD
Singapore, U0 |
Feb 14, 2025 Q4 2024 |
267,755
shares
|
$7.94 Million
2.96% of portfolio
|
Q4 2024
Reduced 20.83%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
219,711
shares
|
$6.52 Million
0.0% of portfolio
|
Q4 2024
Reduced 61.81%
|